Company Updates

The board of directors (the “Board”) of DeClout Limited (the “Company”) refers to the Company’s announcements dated 3 November and 18 November 2015 (the “Announcements”) in relation to the proposed acquisition of 75% interests in Play-E Pte Ltd.. Further to Announcements, the Board wishes to announce that the Company has, on 19 November 2015, allotted […]

November 2015:  Brisbane, Australia Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System, is pleased to announce that a survey of PeriCoach users also reported increased sexual satisfaction after using the device to treat their stress urinary incontinence. Analytica recently conducted a survey of customers, and of the 124 respondents 80 reported that that they […]

20th November 2015, ASX Announcement 2015- An exciting year! Corporate – Listed @ 20 cents (April) – Options listed @ 1 cent (October) Analytical Services – Major contracts in food QC testing and biosimilars (April) – WA Exporter of the Year Award [Healthcare] (September) Diagnostics – Ground breaking predictive test for diabetic kidney disease (June) […]

19th November 2015, ASX Announcement APN Property Group Limited (APN) announced today the launch of the APN Convenience Retail Property Fund (the Fund), the Group’ latest unlisted direct property fund. Forecast to deliver a sustainable distribution yield of 7.20% pa (paid monthly), the Fund’s income is backed by secure long term leases (15 year weighted […]

19th November 2o15, ASX Announcement Highlights:  Letter of Interest (LOI) for project financing received from German bank ECA: Interest in senior-debt project financing utilising German export credit insurance cover Highly experienced international project and export finance specialist Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide an update on the progress of financing […]

18th November 2015, ASX Announcement Dear Fellow Shareholders, Ladies and Gentlemen, Staff of BPS Technology Limited – welcome to the Company’s first full year results since listing. Technically this is our second AGM but last year’s meeting was reporting on a zero trading period before we actually were listed on the ASX which occurred on […]

18th November 2015, ASX Announcement Cancer drug development Prescient Therapeutics Limited (ASX: PTX) has closed its Share Purchase Plan, with strong demand from existing and new investors. Investors have subscribed for $1,201,500 in new shares, with the price per share to be based on a 20% discount to the 5 day volume weighted average price […]

18th November 2015, ASX Announcement Highlights: Big Review TV consumer mobile app now ready for public launch and patents lodged Successful beta testing completed with positive results achieved and over 26,000 downloads to date Mobile app is expected to drive consumer and member engagement and affords the Company the ability to capture a wider market […]

18th November 2015, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL)  is pleased to announce it has received an Australian Government R&D Tax Incentive payment of $309,010 for the year ending 30 June 2015. The Company received the R&D Tax Incentive after spending in excess of $700,000 on R&D […]